Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study.

CONTEXT Down syndrome (DS) is the most common genetic cause of mental retardation. However, the biological determinants of this are poorly understood. The serum sodium/myo-inositol cotransporter gene is located on chromosome 21, and myo-inositol affects neuronal survival and function. Nevertheless, few in vivo studies have examined the role of myo-inositol in DS. OBJECTIVE To determine if people with DS have significant differences in brain myo-inositol concentration from controls and if, within people with DS, this is related to cognitive ability. DESIGN A case-control study. SETTING Outpatient. PARTICIPANTS The sample was composed of 38 adults with DS without dementia (age range, 18-66 years) and 42 healthy controls (age range, 19-66 years). The DS and control groups did not differ significantly in age, sex, ethnic origin, apolipoprotein E status, or handedness. MAIN OUTCOME MEASURES Hippocampal myo-inositol concentration and cognitive performance, as measured by the Cambridge Cognitive Examination. RESULTS Hippocampal myo-inositol concentration was significantly higher in people with DS than in controls (P = .006), and within people with DS, increased myo-inositol concentration was significantly negatively correlated with overall cognitive ability (P = .04). CONCLUSIONS Adults with DS have a significantly increased brain concentration of myo-inositol, and this is associated with reduced cognitive ability. Future studies are required to relate myo-inositol concentration in people with DS to brain development and increased risk for developing Alzheimer disease.

[1]  Karl J. Friston,et al.  CHAPTER 2 – Statistical parametric mapping , 2007 .

[2]  J. O'Brien,et al.  A Comprehensive Review of Proton Magnetic Resonance Spectroscopy Studies in Dementia and Parkinson’s Disease , 2002, Dementia and Geriatric Cognitive Disorders.

[3]  L. Becker,et al.  Excessive expression of synaptojanin in brains with Down syndrome , 2002, Brain and Development.

[4]  G. Alexander,et al.  Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. , 2002, The American journal of psychiatry.

[5]  A. Simmons,et al.  Effects of estrogen replacement therapy on human brain aging: An in vivo 1H MRS study , 2001, Neurology.

[6]  S. Rapoport,et al.  On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models , 2001, Brain Research Reviews.

[7]  M. Berridge,et al.  The versatility and universality of calcium signalling , 2000, Nature Reviews Molecular Cell Biology.

[8]  G. Alexander,et al.  High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. , 1999, The American journal of psychiatry.

[9]  R. Zimmerman,et al.  In vivo brain myo-inositol levels in children with Down syndrome. , 1999, The Journal of pediatrics.

[10]  F. Huppert,et al.  Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG). , 1999, The British journal of clinical psychology.

[11]  G D Pearlson,et al.  MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. , 1999, The American journal of psychiatry.

[12]  P. Fraser,et al.  Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest. , 1998, Journal of molecular biology.

[13]  M. Farrer,et al.  Molecular mapping of alzheimer‐type dementia in Down's syndrome , 1998, Annals of neurology.

[14]  R. Royall,et al.  Improving sterological estimates for the volume of structures identified in three-dimensional arrays of spatial data , 1997, Journal of Neuroscience Methods.

[15]  A. V. van Huffelen,et al.  Prospective study of the prevalence of Alzheimer-type dementia in institutionalized individuals with Down syndrome. , 1997, American journal of mental retardation : AJMR.

[16]  Peter M. G. Munro,et al.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.

[17]  B. Yankner,et al.  Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.

[18]  C. Brayne,et al.  CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. , 1995, The British journal of clinical psychology.

[19]  T. Shonk,et al.  Role of Increased Cerebral myo‐Inositol in the Dementia of Down Syndrome , 1995, Magnetic resonance in medicine.

[20]  N. Spinner,et al.  The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. , 1995, Genomics.

[21]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[22]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  B. Miller.  A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[24]  B. Fruen,et al.  Down's syndrome fibroblasts exhibit enhanced inositol uptake. , 1990, The Biochemical journal.

[25]  Y. Nishizuka,et al.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation , 1988, Nature.

[26]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.

[27]  G. Myers,et al.  Correlates of intelligence and adaptive behaviour in Down's syndrome. , 2008, Journal of mental deficiency research.

[28]  M. Ball,et al.  Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in down syndrome: Quantitative comparison with alzheimer dementia , 1980, Annals of neurology.